[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Using REVLIMID as a Successful Treatment for Myeloma Patients with Kidney Involvement

Using REVLIMID as a Successful Treatment for Myeloma Patients with Kidney Involvement image

Using REVLIMID as a Successful Treatment for Myeloma Patients with Kidney Involvement

Webinar
event Sep 14, 2022 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Doctors are hesitant to treat myeloma patients with kidney involvement with lenalidomide (REVLIMID) or other drugs that could be potentially harmful to kidney production. Learn with us if REVLIMID can be used successfully in patients with kidney involvement and come with your questions.

Schedule & Agenda

The panelist Audrey Burton-Bethke
07:00 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Marc Braunstein.
The panelist Marc Braunstein, MD, PhD
07:05 PM
Presentation
Marc Braunstein, MD, PhD
Dr. Braunstein talks about using REVLIMID as a treatment for myeloma patients with kidney involvement.
Event panelist Audience
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Marc Braunstein, MD, PhD
Marc Braunstein, MD, PhD

Marc Braunstein, MD, PhD is a board-certified hematologist/oncologist with a long-standing interest in plasma cell disorders. He is a part of the NYU Perlmutter Cancer Center's multiple myeloma and cellular therapy programs and serve as Associate Professor of Medicine at NYU Grossman Long Island School of Medicine where he co-direct the medical school hematology curriculum and also serves as Director of the hematology/oncology fellowship program. His clinical research focus is on the use of novel immunotherapy combinations to treat multiple myeloma. As part of his role, he also focuses on medical education and serves on education committees for the American Society of Hematology and American Society of Clinical Oncology, as well as volunteer committees with the American Society of Clinical Oncology and American College of Physicians. In his free time he volunteers with the Leukemia and Lymphoma Society, spends time with his family, and enjoys playing guitar and mandolin.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Myeloma and Kidney Involvement group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Follicular lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.